DMF GI Side Effects – Diroximel Fumarate Alternative — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — GI symptoms often improve over the first 2–3 months; if persistent, consider slow dose re-escalation, taking with high-fat food, or switching to diroximel fumarate (a related prodrug with fewer GI side effects)
DMF commonly causes GI side effects (nausea, diarrhoea, abdominal pain) in ~30–40% of patients, usually worst in the first month and often improving over 2–3 months. Management: taking with food (particularly high-fat meals), slow dose titration, symptomatic relief (anti-emetics, antidiarrhoeals). Diroximel fumarate (Vumerity) is a newer prodrug of monomethyl fumarate with a different formulation that causes significantly fewer GI side effects than DMF while having equivalent efficacy. Switching to diroximel fumarate is a reasonable option for persistent DMF GI intolerance. A: Persistent GI symptoms may warrant switching but are not an absolute stop. C: GI symptoms are very common. D: Long-term metoclopramide risks tardive dyskinesia. E: Increasing the dose would worsen GI effects.
Reference: DMF SmPC; Diroximel Fumarate SmPC; NICE TA320